Company: UPC
Filing Date: 2025-01-30
Form Type: 6-K
Source: 0001213900-25-008083
Chunk: 0

Company: Universe Pharmaceuticals INC
Filing Date: 2025-01-30
Form: 6-K
Chunk 0
---
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________ FORM 6-K _______________ REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2025 Commission file number: 001-40231 _______________ Universe Pharmaceuticals INC _______________ 265 Jingjiu Avenue
Jinggangshan Economic and Technological Development Zone
Ji’an, Jiangxi, China 343100
+86-0796-8403309
(Address of principal executive offices) _______________ Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 4 0-F. Form 20 -F ☒Form 40 -F ☐

In connection with an Extraordinary General Meeting of Shareholders of Universe Pharmaceuticals INC, a company incorporated under the laws of the Cayman Islands (the “Company”), the Company hereby furnishes the following documents: Exhibits

1

SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| Date: January 30, 2025 |     | Universe Pharmaceuticals INC. 
 By:                           |     | /s/ Gang Lai            |
|:-----------------------|:----|:------------------------------|:----|:------------------------|
|                        |     |                               |     | Gang Lai                |
|                        |     |                               |     | Chief Executive Officer |

2